During the past decade, Royal Melbourne Hospital, Department of Respiratory Medicine conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Royal Melbourne Hospital, Department of Respiratory Medicine" are "Fabry Disease" (1 trials) and "Insomnia Disorder" (1 trials). Many other conditions were trialed in "Royal Melbourne Hospital, Department of Respiratory Medicine" in a lesser frequency.

Most popular intervention types in "Royal Melbourne Hospital, Department of Respiratory Medicine" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Daridorexant 25 mg" (1 trials), "Daridorexant 50 mg" (1 trials), "Lucerastat" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Royal Melbourne Hospital, Department of Respiratory Medicine" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Royal Melbourne Hospital, Department of Respiratory Medicine". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Royal Melbourne Hospital, Department of Respiratory Medicine, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Royal Melbourne Hospital, Department of Respiratory Medicine, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".